Chair: A. Ebert (Göttingen), F. Weinberger (Hamburg)
| 12:15 | (V159) | Introduction |
| F. Weinberger (Hamburg) | ||
| 12:20 | (V160) | Gene therapy – Current status and future perspectives |
| L. Zelarayán (Göttingen) | ||
| 12:35 | Diskussion | |
| 12:40 | (V161) | Optimizing viral vectors for the heart |
| O. J. Müller (Kiel) | ||
| 12:55 | Diskussion | |
| 13:00 | (V162) | Antisense oligonucleotides for heart failure |
| N. Grote Beverborg (Groningen, NL) | ||
| 13:15 | Diskussion | |
| 13:20 | (V163) | Translating gene therapy to a clinical application – An industry perspective |
| G. K. Ganjam (Schlieren, CH) | ||
| 13:35 | Diskussion | |
| 13:40 | (V164) | Conclusion |
| A. Ebert (Göttingen) |
